News

Back to All News

LeMaitre Vascular, Inc. (LMAT) - Initiation of Research Coverage

June 25, 2018

Lake Street Capital Markets Analyst Brooks O’Neil initiated coverage of LeMaitre Vascular, Inc. (LMAT), with a BUY rating and price target of $45.00 (LMAT $35.18). LeMaitre develops, manufactures and markets medical devices  and biologics for the treatment of peripheral vascular disease.

Contact Us

Phone
612.326.1305

US Mail
920 Second Avenue South
Suite 700
Minneapolis, MN 55402

Email
Email Us

Find Us